Drug Delivery Business12d
Insulet expands Omnipod 5 to more countries, prices $450M offering
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...
Modern Healthcare5d
FDA warns Dexcom over continuous glucose monitor testing
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Medscape7d
Dexcom’s 15-day CGM Adds Wear Time, Accuracy to Current G7
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Nasdaq5d
DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor
The G7 sensor can now be integrated with Omnipod 5 Automated Insulin Delivery System, NovoPen 6, and NovoPen Echo Plus, expanding its utility. Dexcom also remains the only CGM provider offering ...
15.5-day G7 integrated continuous glucose monitor in adults with diabetes shows positive results
In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...
MedTech Dive6d
Dexcom COO on 15-day glucose sensor, Type 2 coverage
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Yahoo Finance12d
Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care
2 New Dexcom G7 automated insulin delivery and smart insulin pen integrations also announced at ATTD reinforce the company’s status as the most connected CGM brand in the world. 3 During the ...